Masahiro Tajiri
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: April 08, 2014
Net clinical benefit of rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation: a subgroup analysis of J-ROCKET AF.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: September 30, 2013
Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: August 13, 2013
Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation in relation to the CHADS2 score: a subgroup analysis of the J-ROCKET AF trial.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: July 12, 2013
Confirmation of model-based dose selection for a Japanese phase III study of rivaroxaban in non-valvular atrial fibrillation patients.
Journal: Drug metabolism and pharmacokinetics
Published: January 23, 2013
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: December 12, 2012
Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation for the secondary prevention of stroke: a subgroup analysis of J-ROCKET AF.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: October 24, 2012
Model-based dose selection for phase III rivaroxaban study in Japanese patients with non-valvular atrial fibrillation.
Journal: Drug metabolism and pharmacokinetics
Published: July 21, 2012
Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: June 06, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026